Gardasil News and Research

RSS

Gardasil is a vaccine that prevents the types of genital human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts. The vaccine, Gardasil, is given in three shots over six-months. The vaccine is routinely recommended for 11 and 12 year old girls. It is also recommended for girls and women age 13 through 26 who have not yet been vaccinated or completed the vaccine series.

Challenges parents, physicians face in addressing HPV vaccine

The AP/Washington Post on Sunday examined the challenges parents and physicians face in addressing the issues associated with Merck's human papillomavirus vaccine Gardasil (Irvine, AP/Washington Post, 8/27).

30 Aug 2006

History of cervical cancer, HPV vaccine development

The New York Times on Tuesday examined the development of vaccines to prevent transmission of the human papillomavirus, which can cause cervical cancer.

30 Aug 2006

Australian girls lead the field in cervical cancer vaccination programme

Australian females will be one jump ahead of some of their counterparts elsewhere in the world with the first vaccinations against cervical cancer taking place in Brisbane today.

28 Aug 2006

Cervical cancer vaccine tipped for nine year olds

Health experts in the UK are considering vaccinating young girls of primary school age against the human papilloma virus.

28 Aug 2006

Doctors say HPV vaccine should be given to everyone

A new vaccine which will protect women against four types of the human papillomavirus (HPV) known to cause cervical cancer will be available within weeks in the UK.

31 Jul 2006

Canada ready to vaccinate against human papillomavirus

Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.

19 Jul 2006

Women who harbor multiple HPV type infections are at higher risk for cervical lesions

The risk for developing the tissue abnormalities, or lesions, that typically precede cervical cancer is much higher for women infected with multiple genotypes of the human papillomavirus (HPV) than previously reported.

10 Jul 2006

CDC recommends human papillomavirus virus vaccination

CDC Advisory Committee Recommends Human Papillomavirus Virus Vaccination Vaccine considered highly effective in preventing infections that are the cause of most cervical cancers.

29 Jun 2006

Vaccine no replacement for Pap test

The Cancer Council Australia cautioned that the vaccine was not a substitute for the Pap screen and that all women aged 18-69 should continue regular two year screening.

27 Jun 2006

FDA approves cervical cancer vaccine

The Federal Drug Administration (FDA) in the U.S. has recently given its approval for a new vaccine which protects against the human papillomavirus known as HPV.

12 Jun 2006

New era in cancer prevention

Nearly two decades ago, researchers at the National Cancer Institute (NCI) and other institutions began searching for the underlying causes of cervical cancer.

9 Jun 2006

FDA approves Gardasil as a treatment for cervical cancer

Merck & Co. has announced that the U.S. Food and Drug Administration (FDA) approved Gardasil as a treatment for cervical cancer, vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low-grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18.

9 Jun 2006